ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

General Practice

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

10,868Medicare Part D Prescriptions Filled, Including Refills

Rank: 5 out of 21

$580K Total Retail Price of All Prescriptions

Rank: 5 out of 21

335 Patients Receiving at Least One Drug in Part D
72%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Kansas
Lower avg

Schedule Two
Controlled Substances

13% of this provider’s 335 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

25% of this provider’s 335 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

3% of this provider’s 6,830 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$53 was the average price of a prescription from this provider, compared to $48 among peers.

Prescriptions per Patient

32 is the average number of prescriptions (including refills) per patient, compared to an average of 25.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Kansas
LEVOTHYROXINE SODIUM 477 397 1 1
HYDROCODONE-ACETAMINOPHEN 391 202 S3 2 3
ATENOLOL 284 201 3 13
FUROSEMIDE 230 128 4 5
LISINOPRIL 229 193 5 7
OMEPRAZOLE 229 129 5 4
CEPHALEXIN 218 115 7 54
GABAPENTIN 205 105 8 11
POTASSIUM CHLORIDE 195 155 9 6
ZOLPIDEM TARTRATE 188 112 10 21
SIMVASTATIN 185 138 11 2
METFORMIN HCL 167 118 12 10
WARFARIN SODIUM 154 120 13 9
BUMETANIDE 152 126 14 49
FLUOXETINE HCL 148 72 15 69
HYDROCHLOROTHIAZIDE 139 129 16 14
AMLODIPINE BESYLATE 138 130 17 8
MORPHINE SULFATE ER 126 22 S2 18 100
NEXIUM 119 61 19 25
LISINOPRIL-HYDROCHLOROTHIAZIDE 116 79 20 51
METOPROLOL TARTRATE 112 104 21 15
ATORVASTATIN CALCIUM 106 88 22 19
CYCLOBENZAPRINE HCL 105 0 R 23 43
AZITHROMYCIN 104 63 24 37
PREDNISONE 101 85 25 24
SPIRONOLACTONE 98 79 26 44
FAMOTIDINE 95 60 27 62
PAROXETINE HCL 95 91 27 41
DIGOXIN 94 82 29 29
MORPHINE SULFATE 93 16 S2 30 112
ALLOPURINOL 86 74 31 23
NAPROXEN 82 47 32 117
CLOPIDOGREL 80 51 33 46
PROAIR HFA 79 46 34 39
GLIMEPIRIDE 79 44 34 42
AMOXICILLIN 79 52 34 119
AMITRIPTYLINE HCL 79 25 R 34 56
PLAVIX 73 49 38 75
NAMENDA 72 60 39 28
OXYCODONE HCL-ACETAMINOPHEN 62 0 S2 40 135
LOSARTAN POTASSIUM 61 44 41 17
DIOVAN 60 58 42 66
ESTRADIOL 59 54 R 43 100
DOXYCYCLINE HYCLATE 58 32 44 71
CLINDAMYCIN HCL 57 19 45 143
LANTUS 55 26 46 34
RISPERIDONE 54 26 47 46
CARVEDILOL 54 54 47 26
ACETAMINOPHEN-CODEINE 53 29 S3 49 150
LIDODERM 52 23 50 99
POLYETHYLENE GLYCOL 3350 52 35 50 18
FLUCONAZOLE 52 24 50 107
PHENYTOIN SODIUM EXTENDED 52 0 50 88
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.